Shogo Oki

931 total citations
44 papers, 734 citations indexed

About

Shogo Oki is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Cellular and Molecular Neuroscience. According to data from OpenAlex, Shogo Oki has authored 44 papers receiving a total of 734 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 14 papers in Endocrinology, Diabetes and Metabolism and 9 papers in Cellular and Molecular Neuroscience. Recurrent topics in Shogo Oki's work include Neuropeptides and Animal Physiology (8 papers), Receptor Mechanisms and Signaling (7 papers) and Pituitary Gland Disorders and Treatments (6 papers). Shogo Oki is often cited by papers focused on Neuropeptides and Animal Physiology (8 papers), Receptor Mechanisms and Signaling (7 papers) and Pituitary Gland Disorders and Treatments (6 papers). Shogo Oki collaborates with scholars based in Japan, United States and Netherlands. Shogo Oki's co-authors include Hiroo Imura, Yoshikatsu Nakai, Kazuwa Nakao, Junichi Fukata, Hisato Jingami, Kentaro Shiraki, Seiji Muro, Shin Yonemitsu, Takaaki Yoshimasa and Akio Kuwayama and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Clinical Endocrinology & Metabolism and Biochemical and Biophysical Research Communications.

In The Last Decade

Shogo Oki

44 papers receiving 677 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shogo Oki Japan 15 327 316 222 130 111 44 734
S. Heisler Canada 16 380 1.2× 222 0.7× 150 0.7× 110 0.8× 114 1.0× 42 756
M Munemura Japan 11 356 1.1× 278 0.9× 228 1.0× 76 0.6× 99 0.9× 27 737
Colette N. Thaw United States 13 397 1.2× 334 1.1× 273 1.2× 73 0.6× 47 0.4× 20 750
A. E. Jones United Kingdom 16 238 0.7× 254 0.8× 462 2.1× 117 0.9× 86 0.8× 29 922
Marvin Brown United States 10 243 0.7× 243 0.8× 116 0.5× 62 0.5× 87 0.8× 12 535
Richard L. Taylor United States 14 323 1.0× 318 1.0× 90 0.4× 104 0.8× 51 0.5× 19 666
R H Goodman United States 7 421 1.3× 361 1.1× 283 1.3× 49 0.4× 30 0.3× 10 824
P.V. Bertrand United Kingdom 13 263 0.8× 188 0.6× 422 1.9× 56 0.4× 55 0.5× 32 838
M A Takiyyuddin United States 14 402 1.2× 210 0.7× 179 0.8× 76 0.6× 40 0.4× 20 856
Tetsuya Inui Japan 9 283 0.9× 426 1.3× 82 0.4× 123 0.9× 22 0.2× 10 565

Countries citing papers authored by Shogo Oki

Since Specialization
Citations

This map shows the geographic impact of Shogo Oki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shogo Oki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shogo Oki more than expected).

Fields of papers citing papers by Shogo Oki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shogo Oki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shogo Oki. The network helps show where Shogo Oki may publish in the future.

Co-authorship network of co-authors of Shogo Oki

This figure shows the co-authorship network connecting the top 25 collaborators of Shogo Oki. A scholar is included among the top collaborators of Shogo Oki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shogo Oki. Shogo Oki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oki, Shogo, et al.. (2021). Arginine and its Derivatives Suppress the Opalescence of an Antibody Solution. Journal of Pharmaceutical Sciences. 111(4). 1126–1132. 7 indexed citations
2.
3.
Oki, Shogo, et al.. (2018). Arginine suppresses opalescence and liquid–liquid phase separation in IgG solutions. International Journal of Biological Macromolecules. 118(Pt B). 1708–1712. 22 indexed citations
4.
Oki, Shogo, Takahiro Nonaka, & Kentaro Shiraki. (2018). Specific solubilization of impurities in culture media: Arg solution improves purification of pH-responsive tag CspB50 with Teriparatide. Protein Expression and Purification. 146. 85–90. 5 indexed citations
5.
Oki, Shogo, Kazuki Iwashita, Masahiro Kimura, Hideaki Kano, & Kentaro Shiraki. (2017). Mechanism of co-aggregation in a protein mixture with small additives. International Journal of Biological Macromolecules. 107(Pt B). 1428–1437. 26 indexed citations
6.
Yoshizawa, Shunsuke, Shogo Oki, Tsutomu Arakawa, & Kentaro Shiraki. (2017). Trimethylamine N-oxide (TMAO) is a counteracting solute of benzyl alcohol for multi-dose formulation of immunoglobulin. International Journal of Biological Macromolecules. 107(Pt A). 984–989. 6 indexed citations
7.
Murakami, Takaaki, Takeshi Usui, Yuji Nakamoto, et al.. (2017). Challenging Differential Diagnosis of Hypergastremia and Hyperglucagonemia with Chronic Renal Failure: Report of a Case with Multiple Endocrine Neoplasia Type 1. Internal Medicine. 56(11). 1375–1381. 3 indexed citations
8.
Murakami, Takaaki, Yasutoshi Koga, Daita Kaneda, et al.. (2016). Successful Glycemic Control Decreases the Elevated Serum FGF21 Level without Affecting Normal Serum GDF15 Levels in a Patient with Mitochondrial Diabetes. The Tohoku Journal of Experimental Medicine. 239(2). 89–94. 12 indexed citations
9.
Murakami, Takaaki, Masanori Yoshida, Tomoko Funazo, et al.. (2014). Prolonged Disturbance of Consciousness Caused by Severe Hypophosphatemia: A Report of Two Cases. Internal Medicine. 53(19). 2227–2232. 2 indexed citations
10.
Mori, Keita, Yugo Kanai, Naotetsu Kanamoto, et al.. (2012). Diabetic ketoacidosis accompanied by hypothermia: A case report. Diabetes Research and Clinical Practice. 96(3). 326–330. 8 indexed citations
11.
12.
Oki, Shogo, et al.. (2002). The Sound Generating Mechanism of Xenogryllus Marmoratus. 2002. 95. 1 indexed citations
13.
Ohta, Hitoya, Shigeo Nakaishi, Shogo Oki, et al.. (1998). Bone Scintigraphy in a Case of Oncogenous Osteomalacia. Clinical Nuclear Medicine. 23(7). 467–469. 3 indexed citations
14.
Ohta, Hitoya, et al.. (1996). 99mTc-MIBI accumulation in the parathyroid autograft in a patient with recurrent hyperparathyroidism. Annals of Nuclear Medicine. 10(2). 247–249. 6 indexed citations
15.
Oki, Shogo, et al.. (1987). A Case of Klinefelter's Syndrome Associated with Hypothalamic-Pituitary Dysfunction Caused by an Intracranial Germ Cell Tumor. Endocrinologia Japonica. 34(1). 145–151. 7 indexed citations
16.
Tanaka, Issei, Yoshikatsu Nakai, Kazuwa Nakao, et al.. (1983). γ1-Melanotropin-Like Immunoreactivity in Bovine and Human Adrenocorticotropin-Producing Tissues*. The Journal of Clinical Endocrinology & Metabolism. 56(5). 1080–1083. 8 indexed citations
17.
Nakai, Yoshikatsu, et al.. (1980). EVIDENCE FOR γ-MSH-LIKE IMMUNOREACTIVITY IN ECTOPIC ACTH-PRODUCING TUMORS. The Journal of Clinical Endocrinology & Metabolism. 50(6). 1147–1148. 9 indexed citations
18.
Oki, Shogo, Kazuwa Nakao, Yoshikatsu Nakai, Nicholas Ling, & Hiroo Imura. (1980). ‘γ-MSH’ fragments from ACTH-β-LPH precursor have an affinity for opiate receptors. European Journal of Pharmacology. 64(2-3). 161–164. 18 indexed citations
19.
Nakao, Kazuwa, et al.. (1980). CONCOMITANT SECRETION OF γ-MSH WITH ACTH AND β-ENDORPHIN IN HUMANS. The Journal of Clinical Endocrinology & Metabolism. 51(5). 1205–1207. 44 indexed citations
20.
Nakao, Kazuwa, Shogo Oki, Yoshikatsu Nakai, et al.. (1980). Immunoreactive β-Endorphin and Adrenocorticotropin in Human Cerebrospinal Fluid. Journal of Clinical Investigation. 66(6). 1383–1390. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. Heisler Breakdown of academic impact, for papers by M Munemura Breakdown of academic impact, for papers by Colette N. Thaw Breakdown of academic impact, for papers by A. E. Jones Breakdown of academic impact, for papers by Marvin Brown Breakdown of academic impact, for papers by Richard L. Taylor Breakdown of academic impact, for papers by R H Goodman Breakdown of academic impact, for papers by P.V. Bertrand Breakdown of academic impact, for papers by M A Takiyyuddin Breakdown of academic impact, for papers by Tetsuya Inui
Rankless by CCL
2026